Received May 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | U7899AA | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 2 | LC5484 | IM / RL |
severe purpuric rash of the face and extremities, swelling of the hands, feet and oral lesions associated with malaise, cough, rhinorrhea and poor oral intakewhich began within 24 hours of the vaccines and progressed over the course of a week and the remnants of which are still present 2 1/2 mo later. Was admitted to the hospital and given supportive care and IV antibiotics for an infectious complication of the rash.
none
none
none
none
Leukocytosis with lymphocytosis, elevated CRP, normocytic anemia, thrombocytosis. RPP positive for rhino/enterovirus and RSV. UA negative.